MAP3K14 and diabetes mellitus: Additional adjustment for DM, HTN, DL, and elevated hs‐CRP level did not attenuate the significant association between LMS and advanced fibrosis (FibrosisFIB4, OR 1.66, 95% CI 1.01–2.49, P = 0.015; FibrosisBARD, OR 1.81, 95% CI 1.30–2.51, P < 0.001; Model 3 in Table4).